New Drug for licensing out
| Project Name | Mechanism | Indication | Status | Right |
| YKRH00111 | SGLT-2 | Type 2 Diabetes | Pre-clinical | Global |
|---|---|---|---|---|
| Brucine | New MOA | Anti-inflammatory | Pre-clinical | Global |
| Levofloxacin In Situ Gel | DNA Synthesis Inhibitor | Ophthalmic inflammation | Pre-clinical | Global |
| Paclitaxel siRNA Aptamer | Tubulin Inhibitor | Anti cancer | Pre-clinical | Global |
| siRNA | TRPA1 | Anti cancer | Pre-clinical | Global |